The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pulmonary immune-related adverse events post-immune checkpoint inhibitors (ICI): Real-world experience.
 
Maëlys Yepes
No Relationships to Disclose
 
Emily Zabor
Consulting or Advisory Role - Telperian
 
Xiaoying Chen
No Relationships to Disclose
 
Ameed Bawwab
No Relationships to Disclose
 
Muaz Alsabbagh Alchirazi
No Relationships to Disclose
 
Ahmed Mohamed
No Relationships to Disclose
 
Margarita Fedorova
No Relationships to Disclose
 
Soumya Kondaveety
No Relationships to Disclose
 
Mozafar Elshikh
No Relationships to Disclose
 
Sara Haddad
No Relationships to Disclose
 
Bryan Berube
No Relationships to Disclose
 
Faysal Massad
No Relationships to Disclose
 
Anmol Goyal
No Relationships to Disclose
 
Bridget Kuhn
No Relationships to Disclose
 
Moath Albliwi
No Relationships to Disclose
 
Yang Wang
No Relationships to Disclose
 
Tyler Alban
No Relationships to Disclose
 
Timothy Chan
Leadership - Bristol-Myers Squibb; Cancer Genetics; Illumina
Stock and Other Ownership Interests - Gritstone Bio
Honoraria - Illumina
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Illumina; LG Chem; Pfizer
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Nysnobio (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Neoantigen discovery and genomic biomarkers for immunotherapy response
 
Moaath Mustafa Ali
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Novartis